| Name | Title | Contact Details |
|---|
J Sterling Industries is a Woodbridge, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and licensing agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in Phase 2 clinical development and OGX-225 is currently in pre-clinical development.
With a track record of transformative leadership in healthcare technology, Figueroa will spearhead our efforts to integrate cutting-edge technology, streamline operations, and enhance patient care across our extensive network of community-based clinics.As a dynamic leader, Figueroa brings a wealth of experience in leveraging technology to optimize healthcare delivery. His strategic vision aligns perfectly with our commitment to providing the best possible care to our patients. He will play a pivotal role in advancing our digital infrastructure, fostering innovation, and ultimately, improving outcomes for those we serve.
Scinexa Medical Education Group is a Plainsboro, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Joy Medical Group is a Omaha, NE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.